Resources

Selected
  • 烽火通讯股价突破30元可能性分析
Type of publications
Regions
Diseases
446 results found
2024 ∙ Ardura-Garcia, C. Curtis, N. Zimmermann, P.
Systematic review of the impact of intestinal microbiota on vaccine responses
All age groups Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Cahuapaza-Gutierrez, N. L.
Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series
Adults Older adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Petras, M. Janovska, D. Lomozova, D. Franklova, M. Dlouhy, P. Rosina, J. Lesna, I. K.
Understanding the time-driven shifts of vaccine effectiveness against any and severe COVID-19 before and after the surge of Omicron variants within 2.5 years of vaccination: A meta-regression
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Wang, B. Mohammed, H. Andraweera, P. McMillan, M. Marshall, H.
Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis
Adolescents Adults Meningococcal disease Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Achimas-Cadariu, T. Pasca, A. Jiboc, N. M. Puia, A. Dumitrascu, D. L.
Vaccine Hesitancy among European Parents-Psychological and Social Factors Influencing the Decision to Vaccinate against HPV: A Systematic Review and Meta-Analysis
Europe Parents/caregivers Human papillomavirus (HPV) Acceptance Coverage
Rating:
Not applicable
2024 ∙ White, P. Alberti, H. Rowlands, G. Tang, E. Gagnon, D. Dube, E.
Vaccine hesitancy educational interventions for medical students: A systematic narrative review in western countries
All age groups Acceptance
Rating:
Not applicable
2024 ∙ Abenova, M. Shaltynov, A. Jamedinova, U. Semenova, Y.
Worldwide Child Routine Vaccination Hesitancy Rate among Parents of Children Aged 0-6 Years: A Systematic Review and Meta-Analysis of Cross-Sectional Studies
Parents/caregivers Acceptance
Rating:
Not applicable
2024 ∙ Schnyder, J. L. Bache, B. E. Welkers, M. R. A. Spijker, R. Schaumburg, F. Goorhuis, A. Grobusch, M. P. de Jong, H. K.
Yellow fever breakthrough infections after yellow fever vaccination: a systematic review and meta-analysis
All age groups Yellow fever Efficacy/effectiveness
Rating:
Low
2024 ∙ NACI
NACI Statement on seasonal influenza vaccine for 2024–2025
Recommendation Americas Canada Influenza
Download:
2024 ∙ NACI
Interim guidance on the use of Imvamune® in the context of a routine immunization program
Recommendation Americas Canada Mpox
Download:
Loading...